Literature DB >> 10660599

Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain.

B N Patel1, R J Dunn, S David.   

Abstract

Ceruloplasmin is a copper-containing ferroxidase that is essential for normal iron homeostasis. Whereas ceruloplasmin in plasma is produced and secreted by hepatocytes, in the brain a glycosylphosphatidylinositol (GPI)-anchored form of ceruloplasmin is expressed on the surface of astrocytes. By using a cDNA cloning approach, we have now determined that the GPI-anchored form of ceruloplasmin is generated by alternative RNA splicing. The splicing occurs downstream of exon 18 and replaces the C-terminal 5 amino acids of the secreted form with an alternative 30 amino acids that signal GPI anchor addition. RNase protection analysis demonstrates that the GPI-anchored form is the major form in the brain, whereas the secreted form predominates in the liver. Individuals with aceruloplasminemia, a hereditary deficiency of ceruloplasmin, have severe iron deposition in a number of organs, including the brain where it results in neurodegeneration. Therefore, this novel GPI-anchored form of ceruloplasmin is likely to play an important role in iron metabolism in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660599     DOI: 10.1074/jbc.275.6.4305

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

Review 2.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

3.  Aceruloplasminemia: a case report.

Authors:  Domenico Di Raimondo; Antonio Pinto; Antonino Tuttolomondo; Paola Fernandez; Clara Camaschella; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2008-04-12       Impact factor: 3.397

Review 4.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

Review 5.  Redox cycling in iron uptake, efflux, and trafficking.

Authors:  Daniel J Kosman
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

6.  Role of external loops of human ceruloplasmin in copper loading by ATP7B and Ccc2p.

Authors:  Nunziata Maio; Fabio Polticelli; Giovanni De Francesco; Gianluca Rizzo; Maria Carmela Bonaccorsi di Patti; Giovanni Musci
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

7.  Ceruloplasmin alters intracellular iron regulated proteins and pathways: ferritin, transferrin receptor, glutamate and hypoxia-inducible factor-1α.

Authors:  J Harned; J Ferrell; S Nagar; M Goralska; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2012-02-09       Impact factor: 3.467

8.  sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin.

Authors:  Ryan C McCarthy; Yun-Hee Park; Daniel J Kosman
Journal:  EMBO Rep       Date:  2014-05-27       Impact factor: 8.807

9.  Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors.

Authors:  Sandra L Tye; Anne G Gilg; Lauren B Tolliver; William G Wheeler; Bryan P Toole; Bernard L Maria
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

10.  An inhibition of ceruloplasmin expression induced by cerebral ischemia in the cortex and hippocampus of rats.

Authors:  Yan-Wei Li; Lin Li; Jin-Ying Zhao
Journal:  Neurosci Bull       Date:  2008-02       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.